Nonfunctional neuroendocrine tumors of the pancreas (NF-PNETs) are a heterogeneous
group of neoplasms. Although rare, the incidence of NF-PNETs is increasing significantly …

Pancreatic neuroendocrine tumors (pNETs) constitute a heterogenous group of
malignancies with varying clinical presentation, tumor biology and prognosis. The incidence …

Pancreatic neuroendocrine tumors (pNETs) are a heterogeneous group of tumors with
complicated treatment options that depend on pathological grading, clinical staging, and …

Pancreatic neuroendocrine tumors (pNETs) are rare heterogeneous tumors that have been
steadily increasing in both incidence and prevalence during the past few decades …

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) refer to a group of
heterogeneous cancers of neuroendocrine cell phenotype that mainly fall into one of two …

The vast majority of new pNET diagnoses consist of incidentally discovered lesions on cross-
sectional imaging. The biologic behavior of pNETs is defined by the grade and stage of the …

Patients with pancreatic neuroendocrine tumors (PNET) commonly develop advanced
disease and require systemic therapy. However, treatment options remain limited, in part …

Pancreatic neuroendocrine tumors (PNETs) are a rare group of neoplasms that arise from
multipotent stem cells in the pancreatic ductal epithelium. Most PNETs are nonfunctioning …

Abstract Background Pancreatic neuroendocrine tumors (PNETs) are uncommon
neoplasms that can present with symptoms of hormone overproduction. We evaluated the …

Pancreatic neuroendocrine tumors (PNETs) are neoplasms that arise from the hormone
producing cells of the islets of Langerhans, also known as pancreatic islet cells. PNETs are …